Angew Chem Int Ed Engl. 2024. The Fatal Mushroom Neurotoxin Muscarine is Released from a Harmless Phosphorylated Precursor upon Cellular Injury (PMID 39432715).
Why this study
Our fool's funnel card describes the muscarinic syndrome: sweating, tearing, bradycardia. But a question remained: how does a mushroom hold a potent neurotoxin inside its own tissues without poisoning itself? This paper gives an elegant answer — and explains why muscarine acts precisely after ingestion.
Findings
- In Clitocybe rivulosa mycelium the major natural product is 4′-phosphomuscarine, a previously overlooked phosphorylated compound (structure confirmed by HPLC-MS and NMR plus a synthesized reference).
- The same precursor was detected in the fiber caps Pseudosperma spectrale and Inocybe nitidiuscula — the mechanism is broader than one species.
- At the M3 muscarinic receptor, phosphomuscarine shows only weak affinity — on its own it is nearly harmless.
- On cellular injury (chewing, digestion) the phosphate group is cleaved — and active L-(+)-muscarine is released.
Why it matters
This is a "triggered" toxin: the mushroom stores an inert phosphorylated form and converts it into poison the moment tissue is destroyed — precisely when it is eaten. Practical implications:
- Drying and storage do not neutralise the danger: the precursor remains, and enzymatic release happens inside the gut.
- The muscarinic syndrome is not a surface effect but a biochemical trap keyed to tissue destruction.
- The described mechanism argues against "just a taste": even a small amount of chewed tissue starts the release.